Grant Nolan is a seasoned finance professional with extensive experience in corporate accounting and financial management. Currently serving as Corporate Controller at Colossal Biosciences since September 2024, Grant previously held the position of Assistant Controller at Sonata Therapeutics and progressed through various roles at Kiniksa Pharmaceuticals, including Associate Director of Accounting and Senior Manager of Accounting. Early career experience includes significant roles at EY as an Assurance Senior and internships at EMD Shared Services America and NeoSaej, where Grant developed skills in invoice processing, accounts receivable management, and financial statement preparation. Grant holds a Master’s degree in Accounting from Bentley University and a Bachelor of Science in Accounting from the same institution.
Upgrade to view 0 reports
This person is not in any teams
This person is not in any offices
Colossal Biosciences
2 followers
At Colossal Biosciences, we endeavor to jumpstart nature’s ancestral heartbeat. To see the woolly mammoth thunder upon the tundra once again. To advance the economics of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet can breathe easier. These things, which were not achievable before, are now. In our laboratories. Through our breakthroughs in CRISPR and genetic engineering. We are leading the new charge of bioscience. We accept the responsibility. And we can see the light at the end of it all.